Purine nucleoside phosphorylase inhibitory phosphonate compounds
US7427624B2 · kind B2 · utility
11Cited by
19References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2004 |
| Grant date | Sep 23, 2008 |
| Priority date | — |
| Expiry date | Oct 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/548
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is related to phosphorus substituted purine nucleoside phosphorylase inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.